#

Small caps

: 1309
Viemed provides in-home respiratory support / Photo: Shutterstock
Small Caps·
Home medical services provider Viemed soars on third-quarter financials
REUTERS/Andrew Kelly TPX IMAGES OF THE DAY
Small Caps·
Small caps hit record high after Trump victory
Perfect Corp’s technology allows users to virtually try on hair colors and makeup. Photo: perfectcorp.com
Small Caps·
Beauty-tech company Perfect Corp. seen as undervalued, with 70% upside
Markets believe a Trump White House will be better for smaller firms  / Photo: Reuters / Brendan McDermid
Small Caps·
Small caps surge as Trump victory chances rise
Markets are positioning for the outcome of the U.S. presidential election / Photo: REUTERS / Brendan McDermid
Small Caps·
Small-cap indexes outperform the S&P 500 ahead of the U.S. election
SatixFy will help Telesat to build its satellite network / Photo: X/SatixFy_satcom
Small Caps·
Satcom SatixFy stock surges on new $49 million contract
DDC will soon ask shareholders to approve a reverse stock split / Photo: us.daydaycook.com
Small Caps·
Asian food company DDC falls further amid proposed reverse stock split to avoid delisting
Apple uses Globalstar’s satellite network for emergency calls / Photo: Shutterstock
Small Caps·
Satellite communications company Globalstar jumps over 30% on expanded agreement with Apple
Equillium develops treatments for severe autoimmune diseases / Photo: Shutterstock
Small Caps·
Biotech firm Equillium loses third of market value in a day after Ono no-go
An aging population is a challenge for policymakers and an opportunity for investors | Photo: shutterstock
Small Caps·
Eight small-cap stocks that stand to profit from a rapidly aging U.S.
In anticipation of a market rebound, Diamcor is trying to accelerate production at its main mine / Photo: Shutterstock
Small Caps·
Tiffany’s diamond supplier Diamcor sees demand recovery in 2025
ProMIS Neurosciences aims to develop a safer Alzheimer’s treatment / Photo: ProMIS Neurosciences
Small Caps·
Alzheimer’s drugmaker ProMIS gains on positive early trial data
Load more